Cellectar Biosciences, Inc. (CLRB)
1.78
-0.09
(-4.81%)
USD |
NASDAQ |
Oct 02, 16:00
1.82
+0.04
(+2.25%)
After-Hours: 20:00
Cellectar Biosciences Price to Book Value : 0.4917 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.4917 |
| October 01, 2026 | 0.5166 |
| September 30, 2026 | 0.5083 |
| September 29, 2026 | 0.5028 |
| September 28, 2026 | 0.5055 |
| September 25, 2026 | 0.4973 |
| September 24, 2026 | 0.5732 |
| September 23, 2026 | 0.5774 |
| September 22, 2026 | 0.616 |
| September 21, 2026 | 0.6492 |
| September 18, 2026 | 0.6575 |
| September 17, 2026 | 0.663 |
| September 16, 2026 | 0.6492 |
| September 15, 2026 | 0.6409 |
| September 14, 2026 | 0.6381 |
| September 11, 2026 | 0.6381 |
| September 10, 2026 | 0.6547 |
| September 09, 2026 | 0.6533 |
| September 08, 2026 | 0.6658 |
| September 04, 2026 | 0.6547 |
| September 03, 2026 | 0.6492 |
| September 02, 2026 | 0.6713 |
| September 01, 2026 | 0.6796 |
| August 31, 2026 | 0.6934 |
| August 28, 2026 | 0.6989 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.7017 |
| August 26, 2026 | 0.7017 |
| August 25, 2026 | 0.7017 |
| August 24, 2026 | 0.6962 |
| August 21, 2026 | 0.7155 |
| August 20, 2026 | 0.7155 |
| August 19, 2026 | 0.7238 |
| August 18, 2026 | 0.7155 |
| August 17, 2026 | 0.7072 |
| August 14, 2026 | 0.7183 |
| August 13, 2026 | 0.6851 |
| August 12, 2026 | 0.7183 |
| August 11, 2026 | 0.7293 |
| August 10, 2026 | 0.7183 |
| August 07, 2026 | 0.71 |
| August 06, 2026 | 0.6962 |
| August 05, 2026 | 0.6962 |
| August 04, 2026 | 0.7072 |
| August 03, 2026 | 0.7348 |
| July 31, 2026 | 0.71 |
| July 30, 2026 | 0.6989 |
| July 29, 2026 | 0.6851 |
| July 28, 2026 | 0.6906 |
| July 27, 2026 | 0.6685 |
| July 24, 2026 | 0.6658 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Savara, Inc. | 6.877 |
| Vericel Corp. | 5.552 |
| Biogen, Inc. | 1.723 |
Price to Book Value Related Metrics
| Price | 1.78 |
| Earnings Yield | -255.9% |
| Market Cap | 14.69M |